California ephedrine
This article was originally published in The Tan Sheet
Executive Summary
Bill introduced by Assemblywoman Susan Davis (D) is now on state Senate calendar, scheduled for a June 26 hearing. HR 2294 would prohibit sale of supplements containing ephedrine unless labeling refers to potential adverse reactions and contraindications and provides warnings to those under 18 years of age (1"The Tan Sheet" March 6, In Brief). The bill was assigned to the Committee on Business & Profession June 8. California legislation passed earlier this year limits the amount of pseudoephedrine-containing OTCs that can be purchased at one time to curb illegal methamphetamine production. On Capitol Hill, S 486, which includes similar provisions, remains before the House Commerce/Health & Environment subcommittee (2"The Tan Sheet" June 5, p. 6)
You may also be interested in...
California Ephedrine Bill Slated For Senate Consideration Aug. 28
California legislation requiring warning labels on ephedra-containing dietary supplements passed out of the Senate Appropriations Committee Aug. 24 and is expected to go to the state Senate floor the week of Aug. 28. Assembly Bill 2294 was introduced by Assemblywoman Susan Davis (D) Feb. 24.
California Ephedrine Bill Slated For Senate Consideration Aug. 28
California legislation requiring warning labels on ephedra-containing dietary supplements passed out of the Senate Appropriations Committee Aug. 24 and is expected to go to the state Senate floor the week of Aug. 28. Assembly Bill 2294 was introduced by Assemblywoman Susan Davis (D) Feb. 24.
California Ephedrine Bill Slated For Senate Consideration Aug. 28
California legislation requiring warning labels on ephedra-containing dietary supplements passed out of the Senate Appropriations Committee Aug. 24 and is expected to go to the state Senate floor the week of Aug. 28. Assembly Bill 2294 was introduced by Assemblywoman Susan Davis (D) Feb. 24.